The stagnation of pharma players can be attributed to the less-than-effective, old-time spray and pray marketing model
There is a massive dearth of predictive analytics to understand consumer behavior to streamline OTC product marketing, especially FMCG/non-prescription drugs
As the pharma sector has been slow in embracing digital transformation, there is no reliable tool to assess the ROI of the marketing effort
Following the pandemic, there has been an increasing concern in every Indian household vis-à-vis the risks associated with the lack of proper health and hygiene. This new dynamic has resulted in high demand for healthcare products and services, thereby giving players in the pharmaceutical industry a catalyst to broaden their target market. This is to say that the new surge of demand for healthcare products and services has resulted in the emergence of new markets that pharma players can target and leverage.
Up until now, the potential stagnation of pharma players can be…